Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Maintenance of healthy human metabolism depends on a symbiotic consortium among bacteria, archaea, viruses, fungi, and host eukaryotic cells throughout the human gastrointestinal tract. Microbial communities provide the enzymatic machinery and the metabolic pathways that contribute to food digestion, xenobiotic metabolism, and production of a variety of bioactive molecules. These include vitamins, amino acids, short-chain fatty acids (SCFAs), and metabolites, which are essential for the interconnected pathways of glycolysis, the tricarboxylic acid/Krebs cycle, oxidative phosphorylation (OXPHOS), and amino acid and fatty acid metabolism. Recent studies have been elucidating how nutrients that fuel the metabolic processes impact on the ways immune cells, in particular, macrophages, respond to different stimuli under physiological and pathological conditions and become activated and acquire a specialized function. The two major inflammatory phenotypes of macrophages are controlled through differential consumption of glucose, glutamine, and oxygen. M1 phenotype is triggered by polarization signal from bacterial lipopolysaccharide (LPS) and Th1 proinflammatory cytokines such as interferon-γ, TNF-α, and IL-1 β, or both, whereas M2 phenotype is triggered by Th2 cytokines such as interleukin-4 and interleukin-13 as well as anti-inflammatory cytokines, IL-10 and TGF β, or glucocorticoids. Glucose utilization and production of chemical mediators including ATP, reactive oxygen species (ROS), nitric oxide (NO), and NADPH support effector activities of M1 macrophages. Dysbiosis is an imbalance of commensal and pathogenic bacteria and the production of microbial antigens and metabolites. It is now known that the gut microbiota-derived products induce low-grade inflammatory activation of tissue-resident macrophages and contribute to metabolic and degenerative diseases, including diabetes, obesity, metabolic syndrome, and cancer. Here, we update the potential interplay of host gut microbiome dysbiosis and metabolic diseases. We also summarize on advances on fecal therapy, probiotics, prebiotics, symbiotics, and nutrients and small molecule inhibitors of metabolic pathway enzymes as prophylactic and therapeutic agents for metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to regulation of infection and commensal spread, microbiome-immune interactions are implicated in a variety of ‘non-communicable’ gastrointestinal diseases including inflammatory bowel disease (IBD)8 and celiac diseases,9 as well as extra-intestinal disorders ranging from rheumatic arthritis,10 metabolic syndrome,11 neurodegenerative disorder12 to malignancy.13”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [11]
In the citing paper
“Changes in this microbial equilibrium that is, dysbiosis can promote and influence the course of many intestinal and extra-intestinal diseases[14-16].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“Unstimulated macrophages displaying M0 phenotype and exhibiting the differentiation surface markers CD68/ CD80//CD206 acquire and display the M1 phenotype (CD68/CD80//CD206) or M2 phenotype (CD68/ CD80/CD206/) after switching their metabolism and function in response to stimuli or polarization signals that initiate a…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Initial clues for the role of microorganisms in energy homeostasis and obesity appeared from the studies using germ-free animals [76].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 1×
“A collection of 100-400× 10(12) of bacteria inhabits and lives in mutualistic relationships in the human GI tract [3].”
BackgroundMiller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105 · cited 1×
“Finally, bacteria can inhibit the growth of their competitors by long distance microbial communication, via release of metabolites and quorum sensing peptides, which are considered a biological strategy for maintenance of density of commensal species, and elimination of pathogenic bacteria [23, 24].”
Background
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
The gut microbiota in anxiety and depression—A systematic review
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101943 · Cited by 912
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Effects of Virgin Micro- and Nanoplastics on Fish: Trends, Meta-Analysis, and Perspectives
Jacob, H., Besson, M., Swarzenski, P. W., Lecchini, D., & Metian, M. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.9b05995 · Cited by 248
Tegegne, B. A., & Kebede, B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09725 · Cited by 232
“Lacticaseibacillus rhamnosus, when mixed with Lactobacillus gasseri and Bifidobacterium lactis, has been demonstrated to inhibit weight gain in humans, specifically fat tissue mass adiposity, which strengthens the efficacy of probiotics in diabetes [91, 92].”
BackgroundThe promise of the gut microbiome as part of individualized treatment strategies
Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00499-1 · Cited by 217
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
“GM metabolites such as tryptophan and α-galactosylceramide enhance immune organelles to produce IL-17, IL-12 and immunoglobulin A (IgA), which help prevent infiltration of certain microorganism into the bloodstream [74,75].”
BackgroundWhen Rhythms Meet the Blues: Circadian Interactions with the Microbiota-Gut-Brain Axis
Teichman, E. M., O’Riordan, K. J., Gahan, C. G. M., Dinan, T. G., & Cryan, J. F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.008 · Cited by 196
Beneficial Effects of Phenolic Compounds on Gut Microbiota and Metabolic Syndrome
Kasprzak-Drozd, K., Oniszczuk, T., Stasiak, M., & Oniszczuk, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073715 · Cited by 179
Pellegrini, C., Antonioli, L., Calderone, V., Colucci, R., Fornai, M., & Blandizzi, C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101806 · Cited by 174
Gut commensal derived-valeric acid protects against radiation injuries
Li, Y., Dong, J., Xiao, H., Zhang, S., Wang, B., Cui, M., & Fan, S. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1709387 · Cited by 174
Gao, M., Wang, J., Liu, P., Tu, H., Zhang, R., Zhang, Y., Sun, N., & Zhang, K. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02670-5 · Cited by 175
Palmitoylethanolamide: A Natural Compound for Health Management
Clayton, P., Hill, M., Bogoda, N. O., Subah, S., & Venkatesh, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105305 · Cited by 169
“These vectors initiate neuroinflammatory cascades, a hallmark of neurodegenerative disease and psychiatric disorders [85,119].”
BackgroundNrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases
da Costa, R. M., Rodrigues, D., Pereira, C. A., Silva, J. F., Alves, J. V., Lobato, N. S., & Tostes, R. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00382 · Cited by 165
The female reproductive tract microbiotas, inflammation, and gynecological conditions
Gholiof, M., Luca, E. A.-D., & Wessels, J. M. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.963752 · Cited by 153
Feng, S., Zeng, Y., Cai, Z., Wu, J., Chan, L. L., Zhu, J., & Zhou, J. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143558 · Cited by 147
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 128
“In relation to the energy metabolism of the host, gut microbiota is involved in various metabolic functions, including enzymatic digestion, fermentation and absorption of complex dietary carbohydrates and proteins, and providing essential vitamins and amino acids for the host [23,24].”
BackgroundFocus on the Gut–Kidney Axis in Health and Disease
Stavropoulou, E., Kantartzi, K. M., Tsigalou, C., Konstantinidis, T. G., Romanidou, G. V., Voidarou, C. C., & Bezirtzoglou, E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.620102 · Cited by 142
Postbiotics: metabolites and mechanisms involved in microbiota-host interactions
Peluzio, M. D. C. G., Martinez, J. A., & Milagro, F. I. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.004 · Cited by 139
Compositional and functional features of the female premenopausal and postmenopausal gut microbiota
Zhao, H., Chen, J., Li, X., Sun, Q., Qin, P., & Wang, Q. (2019) · FEBS Letters · doi:10.1002/1873-3468.13527 · Cited by 138
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury
Li, Y., Zhang, Y., Wei, K.-X., He, J., Ding, N., Hua, J., Zhou, T., Niu, F., Zhou, G.-C., Shi, T., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.577236 · Cited by 137
Kiecka, A., & Szczepanik, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00489-x · Cited by 138
“It is proven that the gut microbiota plays a key role in metabolic, nutritional, physiological, defense, and immune processes in the human body, and its composition is closely related to emerging intestinal and extraintestinal diseases [19, 20].”
BackgroundMacrophage Polarization in Atherosclerosis
Eshghjoo, S., Kim, D. M., Jayaraman, A., Sun, Y., & Alaniz, R. C. (2022) · Genes · doi:10.3390/genes13050756 · Cited by 136
“However, the current literature supports the notion that M1 Macs accumulate more lipids compared to M2 Macs; M1 Macs induce inflammation and have less activated FAO, while M2 Macs have more active FAO and FA consumption [53,54].”
BackgroundBelizário, J. E., Faintuch, J., & Garay-Malpartida, M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.564194 · Cited by 135
“The inflammatory bowel diseases (IBD), for example, Crohn’s disease (CD) and ulcerative colitis (UC), are chronic diseases in which increases or decreases in relative abundance and diversity bacterial species can be a cause or consequence of the disease (Chang and Lin, 2016; Belizário et al., 2018).”
BackgroundSelf-citationEnhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Zhang, Y., Xiao, Z., Yu, X., Novák, P., Gui, Q., & Yin, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1120168 · Cited by 131
“Intestinal dysbiosis is manifested by an increased abundance of “pro-inflammatory” bacterial strains, such as Ruminococcus gnavus or Bacteroides species, in the gut, while “antiinflammatory” strains, such as Faecalibacterium prausnitzii, show low abundance (112, 113).”
BackgroundVitamin D and Microbiota: Is There a Link with Allergies?
Murdaca, G., Gerosa, A., Paladin, F., Petrocchi, L., Banchero, S., & Gangemi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084288 · Cited by 131
“Moreover, the loss of a specific bacterial species can lead to overreaction or suppression of the innate immune response [42].”
BackgroundUnraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine
Abeltino, A., Hatem, D., Serantoni, C., Riente, A., Giulio, M. M. D., Spirito, M. D., Maio, F. D., & Maulucci, G. (2024) · Nutrients · doi:10.3390/nu16223806 · Cited by 131
“Disruptions in the composition and function of the gut microbiota, termed dysbiosis [1], have been linked to a plethora of health conditions [16], spanning metabolic [17], gastrointestinal [18], and even neurological disorders [19].”
The Oral and Gut Bacterial Microbiomes: Similarities, Differences, and Connections
Maki, K. A., Kazmi, N., Barb, J. J., & Ames, N. J. (2020) · Biological Research For Nursing · doi:10.1177/1099800420941606 · Cited by 120
“Many studies in the microbiome literature refer to dysbiosis as an alteration or interruption in the bacterial community of a specific microbiome (Belizário et al., 2018; Maruvada et al., 2017; Weiss & Hennet, 2017), although determining the differences between physiologic variation and true dysbiosis is difficult wit…”
BackgroundBoyajian, J. L., Ghebretatios, M., Schaly, S., Islam, P., & Prakash, S. (2021) · Nutrients · doi:10.3390/nu13124550 · Cited by 115
“Microbi l communities within the human GI aid in the production and synthesis of vitamins, amino acids, SCFAs and metabolites through enzymatic activity and metabolic pathways [2].”
BackgroundImpact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines
Shoer, S., Shilo, S., Godneva, A., Ben-Yacov, O., Rein, M., Wolf, B. C., Lotan‐Pompan, M., Bar, N., Weiss, E. I., Houri‐Haddad, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41042-x · Cited by 115
“The gut microbiome is believed to play a mediating role in the relationship between diet, metabolism and immunity, by extracting energy from foods otherwise indigestible by the host and producing metabolites and cytokines 8 – 10 .”
BackgroundAlzahrani, J., Hussain, T., Simar, D., Palchaudhuri, R., Abdel‐Mohsen, M., Crowe, S. M., Mbogo, G. W., & Palmer, C. S. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.027 · Cited by 112
“Studies have supported the role ofmetabolic activation of immune cells in promoting chronic inflammation in HIV and IBD.”
BackgroundInfluentialHow Microbiomes Affect Skin Aging: The Updated Evidence and Current Perspectives
Ratanapokasatit, Y., Laisuan, W., Rattananukrom, T., Petchlorlian, A., Thaipisuttikul, I., & Sompornrattanaphan, M. (2022) · Life · doi:10.3390/life12070936 · Cited by 105
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma
Lalani, A.-K. A., Xie, W., Braun, D. A., Kaymakcalan, M., Bossé, D., Steinharter, J. A., Martini, D. J., Simantov, R., Lin, X., Wei, X. X., et al. (2020) · European Urology Oncology · doi:10.1016/j.euo.2019.09.001 · Cited by 100
“Schirmer et al [23] highlight significant microbial taxonomic associations with stimulus-specific monocyte or lymphocyte-derived cytokine responses, and Belizario et al [24] point out the lingering, systemic inflammatory effects of cytokines and the resultant disruption to microbiome health and homeostasis.”
BackgroundDietary Fish, Fish Nutrients, and Immune Function: A Review
Mendivil, C. O. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.617652 · Cited by 99
“The impact of dietary intake on immune function derives not only from the direct physiological effects of its chemical constituents, but at least to a similar extent from the way it shapes the intestinal microbiota, which in turn is a primary stimulus and regulator of diverse immune cells (2).”
BackgroundPathak, P., Helsley, R. N., Brown, A. L., Buffa, J. A., Choucair, I., Nemet, I., Gogonea, C. B., Gogonea, V., Wang, Z., Garcia-Garcia, J. C., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00584.2019 · Cited by 86
Illescas, O., Rodríguez‐Sosa, M., & Gariboldi, M. (2021) · Nutrients · doi:10.3390/nu13072234 · Cited by 98
“Contrary to this normal state, the term dysbiosis refers to an imbalance in the composition and metabolism of the microbiota that has been associated with pro-inflammatory conditions and therefore has been suggested to contribute to the pathogenesis of various diseases, ranging from psychiatric diseases to metabolic d…”
BackgroundThe emerging role of microbiota-derived short-chain fatty acids in immunometabolism
Jasim, S. A., Opulencia, M. J. C., Ramírez‐Coronel, A. A., Abdelbasset, W. K., Abed, M. H., Markov, A. A., Al‐Awsi, G. R. L., Shamsiev, J. A., Hammid, A. T., Shalaby, M. N., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108983 · Cited by 97
Effects of Metabolism on Macrophage Polarization Under Different Disease Backgrounds
Sun, J., Xu, X., & Jin, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880286 · Cited by 93
Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases
Daisley, B. A., Koenig, D. W., Engelbrecht, K. C., Doney, L., Hards, K., Al, K. F., Reid, G., & Burton, J. P. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110087 · Cited by 92
Pathophysiological, immunological, and inflammatory features of long COVID
Böhmwald, K., Diethelm‐Varela, B., Rodríguez‐Guilarte, L., Rivera, T., Riedel, C. A., González, P. A., & Kalergis, A. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341600 · Cited by 91
“Maintaining intestinal microbiota balance is crucial for various functions, such as extracting substrates from the diet for energy production, obtaining vitamins and short-chain fatty acids, and regulating the balance of Th 17 and T reg responses to prevent intestinal in fl ammation (255, 256).”
BackgroundYang, X. W., Tan, M., Guo, J., Xiang, J., Yin, F., Deng, J., Luo, J., Xiao, S., Mo, M., Wang, H., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401963 · Cited by 89
Mo, X., Sun, Y., Liang, X., Li, L., Hu, S., Xu, Z., Liu, S., Zhang, Y., Li, X., & Liu, L. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.119046 · Cited by 85
Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
Zhang, Q., Huang, R., Hu, H., Yu, L., Tang, Q., Tao, Y., Liu, Z., Li, J., & Wang, G. (2020) · iScience · doi:10.1016/j.isci.2020.101460 · Cited by 83
“, 2020), and microbial communities provide molecules and metabolites, which are essential for glycolysis (Belizario et al., 2018).”
BackgroundFarsi, Y., Tahvildari, A., Arbabi, M., Vazife, F., Sechi, L. A., Bonjar, A. H. S., Jamshidi, P. K., Nasiri, M. J., & Mirsaeidi, M. S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.804644 · Cited by 81
Doulberis, M., Papaefthymiou, A., Pοlyzos, S. A., Katsinelos, P., Grigoriadis, N., Srivastava, D., & Kountouras, J. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.19.03058-x · Cited by 80
Gut Microbiome in Retina Health: The Crucial Role of the Gut-Retina Axis
Scuderi, G., Troiani, E., & Minnella, A. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.726792 · Cited by 83
“The use of innovative nutraceutical products, based on probiotics, capable of modulating gut microbial colonization is believed to prevent and combat several pathologies (Belizário et al., 2018).”
BackgroundAguilar‐López, B. A., Moreno‐Altamirano, M. M. B., Dockrell, H. M., Duchen, M. R., & Sánchez‐García, F. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00051 · Cited by 78
Human Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 77
dos Santos, J. C. C., Oliveira, L. F., Noleto, F. M., Gusmão, C. T. P., Brito, G. A. D. C., & Viana, G. S. D. B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373673 · Cited by 76
“It is the commensal bacterial richness and diversity that favors physiological processes and contributes to overall host health (Belizário et al., 2018).”
BackgroundAljeradat, B., Kumar, D., Abdulmuizz, S., Kundu, M., Almealawy, Y. F., Batarseh, D. R., Atallah, O., Ennabe, M., Alsarafandi, M., Alan, A., et al. (2024) · Pathophysiology · doi:10.3390/pathophysiology31020019 · Cited by 77
“The beneficial roles of gut microbiota are the facilitation of metabolism through metabolic pathways and enzymatic activity, the synthesis of vitamins and metabolites, and the inhibition of pathogens [21].”
BackgroundTsubosaka, A., Komura, D., Kakiuchi, M., Katoh, H., Onoyama, T., Yamamoto, A., Abé, H., Seto, Y., Ushiku, T., & Ishikawa, S. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113236 · Cited by 75
Han, S., Kim, J.-K., Park, H.-S., Shin, Y.-J., & Kim, D.-H. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00492-5 · Cited by 69
Using New Technologies to Analyze Gut Microbiota and Predict Cancer Risk
Hemmati, M. A., Monemi, M., Asli, S., Mohammadi, S., Foroozanmehr, B., Haghmorad, D., Oksenych, V., & Eslami, M. (2024) · Cells · doi:10.3390/cells13231987 · Cited by 69
Tango, C. N., Seo, S., Kwon, M., Lee, D.-O., Chang, H. K., & Kim, M. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66607-4 · Cited by 68
Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes
Vezza, T., Abad‐Jiménez, Z., Martí‐Cabrera, M., Rocha, M., & Víctor, V. M. (2020) · Antioxidants · doi:10.3390/antiox9090848 · Cited by 67
“Unfortunately, changes in intestinal microbiota and in microbial metabolite composition, due mainly to an “unhealthy” diet, lifestyle factors, the use of antibiotics [78] and emotional and physiological stress [79], may affect the gut homeostasis and lead to dysregulation of the microbiota composition (also known as d…”
BackgroundEstrada, J. A., & Contreras, I. (2019) · Nutrients · doi:10.3390/nu11051076 · Cited by 66
“Dietary vitamins also play important roles in the modulation of the intestinal microbiome, since bacteria are sensitive to these components [167].”
BackgroundJuárez‐Fernández, M., Porras, D., García‐Mediavilla, M. V., Román-Sagüillo, S., González‐Gallego, J., Nistal, E., & Sánchez‐Campos, S. (2020) · Nutrients · doi:10.3390/nu13010016 · Cited by 66
“The composition of the gut microbiota is based on permanent and transitory bacterial species of 17 different phyla such as Firmicutes, Bacteroidetes and Proteobacteria, which can reach as much as 70%, 30% and 5% of the total abundance, respectively, between others [56].”
BackgroundMetabolites of Gut Microbiota and Possible Implication in Development of Diabetes Mellitus
Guo, Z., Pan, J., Zhu, H., & Chen, Z. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07851 · Cited by 65
Li, X.-G., Chen, M.-X., Zhao, S.-Q., & Wang, X.-Q. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10205-y · Cited by 60
Adipose tissue macrophages: implications for obesity-associated cancer
Li, B., Sun, S., Li, J.-J., Yuan, J.-P., Sun, S., & Wu, Q. (2023) · Military Medical Research · doi:10.1186/s40779-022-00437-5 · Cited by 64
Vidal-Martinez, G., Chin, B., Camarillo, C., Herrera, G. V., Yang, B., Sarosiek, I., & Perez, R. G. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191693 · Cited by 57
“regulating metabolism [1–3], immunity [4], and neu-”
Significance of human microbiome in breast cancer: Tale of an invisible and an invincible
Chadha, J., Nandi, D., Atri, Y., & Nag, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.010 · Cited by 63
Rui, Y., Wan, P., Chen, G., Xie, M., Sun, Y., Zeng, X., & Liu, Z. (2019) · LWT · doi:10.1016/j.lwt.2019.108508 · Cited by 61
Probiotic-enriched milk and dairy products increase gut microbiota diversity: a comparative study
Aljutaily, T., Huarte, E., Martínez‐Monteagudo, S. I., González-Hernández, J. L., Rovai, M., & Sergeev, I. N. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.06.017 · Cited by 59
Ocular Surface Microbiota in Diabetic Patients With Dry Eye Disease
Zhang, Z., Zou, X., Xue, W., Zhang, P., Wang, S., & Zou, H. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.12.13 · Cited by 59
Toda, K., Yamauchi, Y., Tanaka, A., Kuhara, T., Odamaki, T., Yoshimoto, S., & Xiao, J. (2020) · Nutrients · doi:10.3390/nu12010219 · Cited by 58
“Accumulating evidence has indicated that gut microbiota are associated with host health conditions in numerous ways [4], including through energy metabolism and mitochondrial function [5,6].”
BackgroundSharma, R., & Padwad, Y. S. (2020) · Nutrition · doi:10.1016/j.nut.2020.110785 · Cited by 56
Gut microbiota in systemic lupus erythematosus: A fuse and a solution
Chen, Y., Lin, J., Xiao, L., Zhang, X., Zhao, L., Wang, M., & Li, L. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102867 · Cited by 56
Gut Microbiota and Microbiota-Related Metabolites as Possible Biomarkers of Cognitive Aging
Ticinesi, A., Nouvenne, A., Tana, C., Prati, B., & Meschi, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_8 · Cited by 52
Eslami, M., Bahar, A., Hemati, M., Nejad, Z. R., Mehranfar, F., Karami, S., Kobyliak, N. M., & Yousefi, B. (2020) · Diabetic Medicine · doi:10.1111/dme.14415 · Cited by 51
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155254 · Cited by 49
“Interactions betwe n dietary nutrients and GM promote host nutrition and health via various signaling pathways, and to maintain and promote human health, beneficial bacteria should be dominant in the GM [7].”
BackgroundInfluentialEmerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis
Tuazon, J. A., Kilburg-Basnyat, B. J., Oldfield, L. M., Wiscovitch-Russo, R. A., Dunigan, K., Fedulov, A. V., Oestreich, K. J., & Gowdy, K. M. (2022) · Current Allergy and Asthma Reports · doi:10.1007/s11882-022-01034-1 · Cited by 49
Trimethylamine-N-oxide and cerebral stroke risk: A review
Dolkar, P., Deyang, T., Anand, N., Rathipriya, A. G., Hediyal, T. A., Vichitra, C., Krishnamoorthy, N. K., Gorantla, V. R., Bishir, M., Rashan, L. J., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106423 · Cited by 48
Xu, Q., Gao, J., Zhao, R., Li, H., Cui, H., Yuan, Z., Ren, H., Cao, B., & Wei, B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107278 · Cited by 49
Zheng, Y., Gou, X., Zhang, L., Gao, H., Wei, Y., Yu, X., Pang, B., Tian, J., Tong, X., & Li, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00360 · Cited by 47
“Bacterial components contribute to the production of many bioactive molecule types like bile acids and adipokines, which are essential for the interconnected pathways of glycolysis, tricarboxylic acid/Krebs cycle, oxidative phosphorylation (OXPHOS), and amino acid and fatty acid metabolism (Belizario et al., 2018).”
BackgroundDiscovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review
Lazur, J., Hnatyk, K., Kała, K., Sułkowska‐Ziaja, K., & Muszyńska, B. (2023) · Antioxidants · doi:10.3390/antiox12030623 · Cited by 46
Shinjyo, N., Parkinson, J. R. C., Bell, J. D., Katsuno, T., & Bligh, S. W. A. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.01.004 · Cited by 46
“Changes in the intestinal ecosystem could alter intestinal permeability, cause inflammation and modulate bile acid metabolism, short-chain fatty acids and other metabolites, contributing to insulin resistance [202] and progression of diabetes-associated conditions [203,204].”
BackgroundKhanna, S., Bishnoi, M., Kondepudi, K. K., & Shukla, G. (2020) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-020-02852-z · Cited by 44
Galena, A. E., Chai, J., Zhang, J., Bednarzyk, M. S., Perez, D., Ochrietor, J. D., Jahan-Mihan, A., & Arikawa, A. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275275 · Cited by 44
Chulenbayeva, L., Jarmukhanov, Z., Kaliyekova, K., Kozhakhmetov, S., & Kushugulova, A. R. (2025) · Biomolecules · doi:10.3390/biom15071017 · Cited by 44
“Elevated butyrate levels observed in UC could indicate a preserved fermentation capacity compared to CD, where gut dysbiosis and inflammation may impair SCFA production [60].”
The Mediterranean diet and its association with selected gut bacteria
Krznarić, Ž., Bender, D. V., & Meštrović, T. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000587 · Cited by 43
Liu, Y., Zhu, J., Wang, H., Lu, W., LEE, Y. K., Zhao, J., & Zhang, H. (2022) · BMC Genomics · doi:10.1186/s12864-022-09087-2 · Cited by 37
“Recent studies have shown that the gut microbiome affects obesity by influencing energy balance, gut barrier function, inflammation, and the production of significant bioactive factors, including short-chain fatty acids (SCFAs), lipopolysac-charides, and bile acids [12, 13].”
BackgroundLu, M., Li, R. W., Zhao, H., Yan, X., Lillehoj, H. S., Sun, Z., Oh, S., Wang, Y., & Li, Z. (2020) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.05.013 · Cited by 42
The gut–brain connection: microbes’ influence on mental health and psychological disorders
Ataei, P., Kalantari, H., Bodnar, T. S., & Turner, R. J. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1701608 · Cited by 41
“…can trigger a cascade of physiological changes, including heightened neuroin fl ammation, increased oxidative stress, and imbalances in neurotransmitter signaling — factors that are closely associated with the development and progression of psychiatric illnesses (Beliza ́ rio et al., 2018).”
Potential biomarkers of infertility associated with microbiome imbalances
Azpiroz, M. A., Orguilia, L., Palacio, M. I., Malpartida, A., Mayol, S., Gil, M., & Gutiérrez, G. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13438 · Cited by 41
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer
Yang, H. J., & Kim, J. H. (2023) · Korean journal of urology · doi:10.4111/icu.20220370 · Cited by 42
“It has been confirmed that SCFA levels show negative correlations with the risk of obesity, insulin resistance, and type 2 DM [51].”
BackgroundMicrobiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes
Lacerda, R. R. E., Fang, H., Robin, N., Bhatwa, A., Marko, D. M., & Schertzer, J. D. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100610 · Cited by 41
“[31] Beliz ario JE, Faintuch J, Garay-Malpartida M.”
BackgroundThanush, D., Basavaraj, H. C., & Gowrav, M. P. (2023) · Advanced Gut & Microbiome Research · doi:10.1155/2023/6657515 · Cited by 40
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 40
Wu, J., Qiu, M., Zhang, C., Zhang, C., Wang, N., Zhao, F., Liqiao, L. V., Li, J., Lyu-Bu, A. G. A., Wang, T., et al. (2021) · Food & Function · doi:10.1039/d1fo02208c · Cited by 39
Yadav, M., Kapoor, A., Verma, A., & Ambatipudi, K. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00335 · Cited by 39
A decreased abundance of clostridia characterizes the gut microbiota in eosinophilic esophagitis
Kashyap, P., Johnson, S. P., Geno, D. M., Lekatz, H. R., Lavey, C. J., Alexander, J. A., Chen, J., & Katzka, D. A. (2019) · Physiological Reports · doi:10.14814/phy2.14261 · Cited by 38
“Abnormalities in the gut microbiome are associated with perturbations in systemic immune reaction (Belizario et al., 2018) and predisposition to atopic disease such as asthma and eczema (Zimmermann et al., 2019).”
BackgroundInfluentialWarda, A. K., Bettio, P. H. D. A., Hueston, C. M., Benedetto, G. D., Clooney, A. G., & Hill, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00069 · Cited by 37
Matcha green tea beverage moderates fatigue and supports resistance training-induced adaptation
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoüe, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00859-4 · Cited by 36
“In contrast, dysbiosis causes impaired intestinal permeability, accelerating invasion by endotoxins and antigens into the blood stream and disturbing metabolic and immune functions throughout the body [41].”
BackgroundThe Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Antibiotics · doi:10.3390/antibiotics13050392 · Cited by 37
“In summary, alterations in the gut microbiome are associated with a range of metabolic disorders, as suggested by numerous research studies and publications, including the Human Microbiome Project (HMP) [60] and the European MetaHit Project [123].”
BackgroundThe Gut Microbiome-Neuroglia Axis: Implications for Brain Health, Inflammation, and Disease
Camberos-Barraza, J., Guadrón‐Llanos, A. M., & la Herrán-Arita, A. K. D. (2024) · Neuroglia · doi:10.3390/neuroglia5030018 · Cited by 36
Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection
Garmendia, J. V., Sanctis, C. V. D., Hajdúch, M., & Sanctis, J. B. D. (2024) · Microorganisms · doi:10.3390/microorganisms12081641 · Cited by 35
Abange, W. B., Martin, C. G., Nanfack, A. J., Yatchou, L. G., Nusbacher, N. M., Nguedia, C. A., Kamga, H. G., Fokam, J., Kennedy, S., Ndjolo, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87368-8 · Cited by 34
Gut microbiota: Candidates for a novel strategy for ameliorating sleep disorders
Li, L., Liang, T., Jiang, T., Li, Y., Yang, L., Wu, L., Yang, J., Ding, Y., Wang, J., Chen, M., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2228409 · Cited by 33
“Compared to specific-pathogen-free mice, GF mice have reduced immune cell efficiency and production of CD4 + T cells and antibodies (Belizario, Faintuch, and Garay-Malpartida 2018).”
Intestinal Microbiota in Sepsis
Sun, T., Wang, L., & Zhang, H. (2022) · Intensive Care Research · doi:10.1007/s44231-022-00001-8 · Cited by 32
Metadata
- Authors
- Belizário, J. E., Faintuch, J., & Garay-Malpartida, M.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Belizário, José E.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-12-09
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6304917
- OpenAlex
- W2904076340
- Cited by
- 341
- References
- 101
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 55 · 2023: 46 · 2022: 64 · 2021: 47 · 2020: 51 · 2019: 17
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- gut dysbiosis, immunometabolism, macrophage polarization, M1/M2 macrophages, short-chain fatty acids, microbial metabolites, low-grade inflammation, metabolic disorders, obesity, diabetes mellitus, metabolic syndrome, cancer, fecal microbiota transplantation, probiotics, prebiotics, symbiotics, small molecule inhibitors, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Macrophages, Metabolic Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.